Department of Medicine, Endocrine Unit (111N), University of California at San Francisco and Veterans Affairs Medical Center, San Francisco, California 94121, USA.
J Biol Chem. 2010 Nov 19;285(47):36721-35. doi: 10.1074/jbc.M110.162305. Epub 2010 Sep 15.
Dysregulation of microRNAs is observed in many cancers, including breast cancer. In particular, miR-10b appears to play an important role in tumor cell invasion and breast cancer progression. In this study, we investigated hyaluronan (HA)-induced CD44 (a primary HA receptor) interaction with c-Src kinase and the transcriptional factor, Twist, in breast tumor cells (MDA-MB-231 cells). Our results indicate that HA binding to CD44 promotes c-Src kinase activation, which, in turn, increases Twist phosphorylation, leading to the nuclear translocation of Twist and transcriptional activation. Further analyses reveal that miR-10b is controlled by an upstream promoter containing the Twist binding site(s), whereas ChIP assays demonstrate that stimulation of miR-10b expression by HA/CD44-activated c-Src is Twist-dependent in breast tumor cells. This process results in the reduction of a tumor suppressor protein (HOXD10), RhoA/RhoC up-regulation, Rho-kinase (ROK) activation, and breast tumor cell invasion. Treatment of MDA-MB-231 cells with PP2 (a c-Src inhibitor) or Twist-specific siRNAs effectively blocks HA-mediated Twist signaling events, abrogates miR-10b production, and increases HOXD10 expression. Subsequently, this c-Src/Twist signaling inhibition causes down-regulation of RhoA/RhoC expression and impairment of ROK-regulated cytoskeleton function (e.g. tumor cell invasion). To further evaluate the role of miR-10b in RhoGTPase signaling, MDA-MB-231 cells were also transfected with a specific anti-miR-10b inhibitor in order to silence miR-10b expression and block its target functions. Our results demonstrate that anti-miR-10b inhibitor not only enhances HOXD10 expression but also abrogates HA/CD44-mediated tumor cell behaviors in breast tumor cells. Taken together, these findings indicate that the HA-induced CD44 interaction with c-Src-activated Twist plays a pivotal role in miR-10b production, leading to the down-regulation of tumor suppressor protein (HOXD10), RhoGTPase-ROK activation, and tumor cell invasion. All of these events are critical prerequisite steps for the acquisition of metastatic properties by human breast cancer cells.
microRNAs 的失调在许多癌症中都有观察到,包括乳腺癌。特别是,miR-10b 似乎在肿瘤细胞侵袭和乳腺癌进展中发挥重要作用。在这项研究中,我们研究了透明质酸(HA)诱导的 CD44(主要的 HA 受体)与 c-Src 激酶和转录因子 Twist 在乳腺癌细胞(MDA-MB-231 细胞)中的相互作用。我们的结果表明,HA 与 CD44 的结合促进了 c-Src 激酶的激活,而 c-Src 激酶的激活又增加了 Twist 的磷酸化,导致 Twist 向核内易位和转录激活。进一步的分析表明,miR-10b 受含有 Twist 结合位点的上游启动子控制,而 ChIP 实验表明,HA/CD44 激活的 c-Src 刺激 miR-10b 的表达在乳腺癌细胞中是依赖于 Twist 的。这个过程导致肿瘤抑制蛋白(HOXD10)的减少、RhoA/RhoC 的上调、Rho-激酶(ROK)的激活和乳腺癌细胞的侵袭。用 PP2(一种 c-Src 抑制剂)或 Twist 特异性 siRNA 处理 MDA-MB-231 细胞可有效阻断 HA 介导的 Twist 信号事件,阻断 miR-10b 的产生,并增加 HOXD10 的表达。随后,这种 c-Src/Twist 信号抑制导致 RhoA/RhoC 表达的下调和 ROK 调节的细胞骨架功能的损害(例如肿瘤细胞侵袭)。为了进一步评估 miR-10b 在 RhoGTPase 信号中的作用,MDA-MB-231 细胞还被转染了一种特异的抗 miR-10b 抑制剂,以沉默 miR-10b 的表达并阻断其靶功能。我们的结果表明,抗 miR-10b 抑制剂不仅增强了 HOXD10 的表达,而且阻断了 HA/CD44 介导的乳腺癌细胞的肿瘤细胞行为。总之,这些发现表明,HA 诱导的 CD44 与 c-Src 激活的 Twist 的相互作用在 miR-10b 的产生中起关键作用,导致肿瘤抑制蛋白(HOXD10)的下调、RhoGTPase-ROK 的激活和肿瘤细胞的侵袭。所有这些事件都是人类乳腺癌细胞获得转移特性的关键前提步骤。